Cytomedix Re-Launches Chronic Wound Care System Under Aurix Brand
October 14, 2014 08:30 ET
|
Nuo Therapeutics, Inc.
GAITHERSBURG, Md., Oct. 14, 2014 (GLOBE NEWSWIRE) -- Cytomedix (OTCQX:CMXI), a pioneer in biodynamic therapies, today announced that it has re-launched its AutoloGel chronic wound care system under...
Cytomedix to Present at the Rodman & Renshaw Global Investment Conference
September 02, 2014 08:30 ET
|
Nuo Therapeutics, Inc.
GAITHERSBURG, Md., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Cytomedix (OTC:CMXI), a pioneer in biodynamic therapies, today announced that Martin Rosendale, CEO, will present a corporate overview at the 16th...
Cytomedix Partners With Net Health to Expand CED Data Collection Capabilities to Approximately 400 Additional Wound Care Centers
August 20, 2014 09:10 ET
|
Nuo Therapeutics, Inc.
Net Health's WoundExpert® Electronic Medical Record ("EMR") Software to Empower CED Study of AutoloGel™
GAITHERSBURG, Md., Aug. 20, 2014 (GLOBE NEWSWIRE) -- Cytomedix (OTC:CMXI), a...
Cytomedix Reports Second Quarter 2014 Financial Results
August 14, 2014 16:05 ET
|
Nuo Therapeutics, Inc.
Updates on AutoloGel™ Commercialization Efforts
Conference Call Scheduled for Friday, August 15 at 8:00 am Eastern Time
GAITHERSBURG, Md., Aug. 14, 2014 (GLOBE NEWSWIRE) -- Cytomedix,...
Cytomedix to Report Second Quarter 2014 Financial Results on Thursday, August 14, 2014
August 11, 2014 08:45 ET
|
Nuo Therapeutics, Inc.
GAITHERSBURG, Md., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Cytomedix (OTC:CMXI) announced today that it will report financial results for the second quarter of 2014 on Thursday, August 14, 2014, after the...